<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">porozendo</journal-id><journal-title-group><journal-title xml:lang="ru">Остеопороз и остеопатии</journal-title><trans-title-group xml:lang="en"><trans-title>Osteoporosis and Bone Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-2680</issn><issn pub-type="epub">2311-0716</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/osteo13161</article-id><article-id custom-type="elpub" pub-id-type="custom">porozendo-13161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GUIDELINES</subject></subj-group></article-categories><title-group><article-title>Микроархитектоника костной ткани и риск переломов при ревматоидном артрите</article-title><trans-title-group xml:lang="en"><trans-title>Bone microarchitecture and fracture risk in rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0560-3495</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козырева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozyreva</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Витальевна Козырева, младший научный сотрудник</p><p>лаборатория остеопороза</p><p>115522; Каширское ш., д. 34А; Москва</p><p>Researcher ID: HHZ-3451-2022</p></bio><bio xml:lang="en"><p>Maria V. Kozyreva, MD</p><p>115522; 34A, Kashirskoye sh.,; Moscow</p><p>Researcher ID: HHZ-3451-2022</p></bio><email xlink:type="simple">doginya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0961-9785</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демин</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Demin</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Николай Викторович Демин, младший научный сотрудник</p><p>лаборатория остеопороза</p><p>Москва</p><p>Researcher ID: AAF-3400-2021; Scopus Author ID: 7006802179</p></bio><bio xml:lang="en"><p>Nikolay V. Demin, MD</p><p>Moscow</p><p>Researcher ID: AAF-3400-2021; Scopus Author ID: 7006802179</p></bio><email xlink:type="simple">epid@irramn.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2809-0197</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добровольская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dobrovolskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Валерьевна Добровольская, к. м. н., научный сотрудник</p><p>лаборатория остеопороза</p><p>Москва</p><p>Researcher ID: AAF-2921-2021; Scopus Author ID: 57197823569</p></bio><bio xml:lang="en"><p>Olga V. Dobrovolskaya, MD, PhD</p><p>Moscow</p><p>Researcher ID: AAF-2921-2021; Scopus Author ID: 57197823569</p></bio><email xlink:type="simple">olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6759-8367</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитинская</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitinskaya</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Анатольевна Никитинская, к. м. н., старший научный сотрудник</p><p>лаборатория остеопороза</p><p>Москва</p></bio><bio xml:lang="en"><p>Oksana A. Nikitinskaya, MD, PhD</p><p>Moscow</p><p>Researcher ID: AAF-2616-2021; Scopus Author ID: 6504217119</p></bio><email xlink:type="simple">nikitinskaya@niir.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4739-4302</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торопцова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Toroptsova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Владимировна Торопцова, д. м. н., заведующая лабораторией</p><p>лаборатория остеопороза</p><p>Москва</p><p>ResearcherID: I-9030-2017; Scopus Author ID: 6507457856</p></bio><bio xml:lang="en"><p>Natalia V. Toroptsova, MD, PhD</p><p>Moscow</p><p>ResearcherID: I-9030-2017; Scopus Author ID: 6507457856</p></bio><email xlink:type="simple">torop@irramn.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБНУ «Научно-исследовательский институт ревматологии имени В.А. Насоновой»<country>Россия</country></aff><aff xml:lang="en">V.A. Nasonova Research Institute of Rheumatology<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>04</month><year>2024</year></pub-date><volume>27</volume><issue>1</issue><fpage>42</fpage><lpage>48</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Козырева М.В., Демин Н.В., Добровольская О.В., Никитинская О.А., Торопцова Н.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Козырева М.В., Демин Н.В., Добровольская О.В., Никитинская О.А., Торопцова Н.В.</copyright-holder><copyright-holder xml:lang="en">Kozyreva M.V., Demin N.V., Dobrovolskaya O.V., Nikitinskaya O.A., Toroptsova N.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.osteo-endojournals.ru/jour/article/view/13161">https://www.osteo-endojournals.ru/jour/article/view/13161</self-uri><abstract><sec><title>   ОБОСНОВАНИЕ</title><p>   ОБОСНОВАНИЕ. Микроархитектонику трабекулярной костной ткани в настоящее время можно оценить с помощью специальной программы для рентгенденситометров по определению трабекулярного костного индекса (ТКИ).</p></sec><sec><title>   ЦЕЛЬ</title><p>   ЦЕЛЬ. Оценить микроархитектонику костной ткани и риск переломов у пациентов с ревматоидным артритом (РА).</p></sec><sec><title>   МАТЕРИАЛЫ И МЕТОДЫ</title><p>   МАТЕРИАЛЫ И МЕТОДЫ. В одномоментном исследовании приняли участие 95 женщин в постменопаузе с РА (средний возраст 62,3 ± 8,1 года). Проведено анкетирование с помощью специально разработанного опросника, лабораторное обследование, рентгеновская остеоденситометрия поясничного отдела позвоночника (L1–L4), проксимального отдела бедра с определением ТКИ. Оценен риск основных остеопоротических переломов (ООП) с помощьюкалькулятора FRAX без или со стандартизацией по ТКИ.</p></sec><sec><title>   РЕЗУЛЬТАТЫ</title><p>   РЕЗУЛЬТАТЫ. У 41 (43,2 %) пациентки выявлен остеопороз (ОП) хотя бы в одной области измерения, при этом в L1–L4 — у 26,3 %, в шейке бедра (ШБ) — у 22,1 % и в проксимальном отделе бедра в целом — у 11,6 %. Среди обследованных женщин 35,8 % имели нормальную, 25,3 % — частично деградированную и 38,9 % — деградированную микроархитектонику по ТКИ. У пациентов с переломами в анамнезе низкий ТКИ выявлялся значимо чаще по сравнению с больными без переломов (р &lt; 0,05). ТКИ негативно коррелировал с возрастом (r = -0,30, р = 0,003), длительностью постменопаузы (r = -0,26, р = 0,014), кумулятивной дозой глюкокортикоидов (ГК) (r = -0,34, р = 0,045) и позитивно — с МПК L1–L4 (r = 0,43, р &lt; 0,001), МПК ШБ (r = 0,21, p = 0,038) и общим показателем бедра (ОПБ) (r = 0,23, p = 0,02). Нормальные показатели МПК в L1–L4 и при этом деградированную микроархитектонику костной ткани по ТКИ имели 9,5 % лиц с РА. Высокий риск переломов по FRAX выявлен у 47 (49,5 %) женщин, а введение в алгоритм значения ТКИ увеличило число таких пациентов до 52 (54,7 %).</p></sec><sec><title>   ЗАКЛЮЧЕНИЕ</title><p>   ЗАКЛЮЧЕНИЕ. У 43,2 % женщин в постменопаузе с РА диагностирован ОП, у 38,9 % выявлена деградированная микроархитектоника костной ткани по ТКИ. Установлены негативные ассоциации между ТКИ и возрастом, длительностью постменопаузы, кумулятивной дозой ГК, а позитивные — с показателями МПК во всех отделах скелета. Введение показателя ТКИ при расчете риска ООП по FRAX позволило перераспределить пациентов в группах риска, в результате чего высокий риск имели 54,7 % больных.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   BACKGROUND</title><p>   BACKGROUND: Microarchitecture of trabecular bone tissue can currently be evaluated using a special program for dual-energy X-ray absorptiometry (DXA) to determine the trabecular bone score (TBS).</p></sec><sec><title>   AIM</title><p>   AIM: to assess bone microarchitecture and fracture risk in patients with rheumatoid arthritis (RA).</p></sec><sec><title>   MATERIALS AND METHODS</title><p>   MATERIALS AND METHODS: a cross — sectional study included 95 postmenopausal women with confirmed diagnosis of RA (mean age 62.3 ± 8.1 years). The survey was conducted using a specially designed questionnaire, laboratory examination, DXA of the lumbar spine (L1–L4) with the determined of TBS and proximal femur. The risk of major osteoporotic fractures (MOF) was assessed using FRAX calculator without or with TBS standardization.</p></sec><sec><title>   RESULTS</title><p>   RESULTS: 41 (43.2 %) patients had osteoporosis (OP) in at least one measurement area, while in L1–L4 — 26.3 %, in the femoral neck (FN) — 22.1 % and in total hip (TH) — 11.6 % persons. 35.8 % women had normal, 25.3 % — partially degraded and 38.9 % — degraded microarchitecture according to TBS. In patients with a history of fractures, low TBS was detected significantly more often than in people without fractures (p &lt; 0.05). TBS was negatively correlated with age with age (r = -0.30, p = 0.003), duration of postmenopause (r = -0.26, p = 0.014), cumulative dose of glucocorticoids (GCs) (r = -0.34, p = 0.045) and positively correlated with BMD L1-L4 (r = 0.43, p &lt; 0.001), BMD of the FN (r = 0.21, p = 0.038) and BMD TH (r = 0.23, p = 0.02). Normal BMD values in L1–L4 and at the same time degraded microarchitecture according to TBS were in 9.5 % RA persons. A high risk of fractures according to FRAX was detected in 47 (49.5 %) women, and FRAX adjusted for TBS increased the number of such patients to 52 (54.7 %).</p></sec><sec><title>   CONCLUSION</title><p>   CONCLUSION: OP was diagnosed in 43.2 % of postmenopausal women with confirmed RA, and 38.9 % had degraded bone microarchitecture by TBS. Negative associations were found between TBS and age, duration of postmenopause, cumulative dose of GCs, and positive associations with BMD in all parts of the skeleton. Including TBS values into the FRAX calculator made it possible to redistribute patients into risk groups, as a result of which 54.7 % of patients had a high risk of MOF.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ревматоидный артрит</kwd><kwd>остеопороз</kwd><kwd>трабекулярный костный индекс</kwd><kwd>микроархитектоника кости</kwd><kwd>минеральная плотность кости</kwd><kwd>глюкокортикоиды</kwd><kwd>ревматические заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rheumatoid arthritis</kwd><kwd>osteoporosis</kwd><kwd>trabecular bone score</kwd><kwd>bone microarchitecture</kwd><kwd>bone mineral density</kwd><kwd>glucocorticoids</kwd><kwd>rheumatic diseases</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование выполнено в рамках научно-исследовательской работы ФГБНУ «НИИР им. В. А. Насоновой». Государственное задание № 1021051403074-2</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>The study was carried out within the framework of the scientific research work of the Federal State Budgetary Budgetary Institution "Nasonova Research Institute". State assignment No. 1021051403074-2</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е.Л., Каратеев Д.Е., Балабанова Р.М. Ревматоидный артрит. В кн.: Ревматология. Национальное руководство. Под ред. Е.Л. Насонова, В.А. Насоновой. Москва: ГЭОТАР-Медиа; 2008. С. 290–331.</mixed-citation><mixed-citation xml:lang="en">Nasonov EL, Karateev DE, Balabanova RM. Revmatoidnyj artrit. V kn.: Revmatologiya. Nacional'noe rukovodstvo. Pod red. EL Nasonova, VA Nasonovoj. Moskva: GEOTAR-Media; 2008: S. 290–331 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int. 2011;22(2):421-433. doi: 10.1007/s00198-010-1319-x</mixed-citation><mixed-citation xml:lang="en">Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int. 2011;22(2):421-433. doi: 10.1007/s00198-010-1319-x</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">El-Gazzar A, Högler W. Mechanisms of bone fragility: From osteogenesis imperfecta to secondary osteoporosis. Int J Mol Sci. 2021. doi: 10.3390/ijms22020625</mixed-citation><mixed-citation xml:lang="en">El-Gazzar A, Högler W. Mechanisms of bone fragility: From osteogenesis imperfecta to secondary osteoporosis. Int J Mol Sci. 2021. doi: 10.3390/ijms22020625</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lodder MC. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis. 2004;63(12):1576-1580. doi: 10.1136/ard.2003.016253</mixed-citation><mixed-citation xml:lang="en">Lodder MC. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis. 2004;63(12):1576-1580. doi: 10.1136/ard.2003.016253</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lodder MC, Haugeberg G, Lems WF, et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: The Oslo-Truro-Amsterdam (OSTRA) Collaborative Study. Arthritis Care Res. 2003. doi: 10.1002/art.10996</mixed-citation><mixed-citation xml:lang="en">Lodder MC, Haugeberg G, Lems WF, et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: The Oslo-Truro-Amsterdam (OSTRA) Collaborative Study. Arthritis Care Res. 2003. doi: 10.1002/art.10996</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sinigaglia L, Nervetti A, Mela Q et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol. 2000;27(11):2582-9</mixed-citation><mixed-citation xml:lang="en">Sinigaglia L, Nervetti A, Mela Q et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol. 2000;27(11):2582-9</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County rheumatoid arthritis register. Arthritis Rheum. 2000;43(3):522. doi: 10.1002/1529-0131(200003)43:3&lt;522::AID-ANR7&gt;3.0.CO;2-Y</mixed-citation><mixed-citation xml:lang="en">Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County rheumatoid arthritis register. Arthritis Rheum. 2000;43(3):522. doi: 10.1002/1529-0131(200003)43:3&lt;522::AID-ANR7&gt;3.0.CO;2-Y</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">GOUGH A. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344(8914):23-27. doi: 10.1016/S0140-6736(94)91049-9</mixed-citation><mixed-citation xml:lang="en">GOUGH A. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344(8914):23-27. doi: 10.1016/S0140-6736(94)91049-9</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Muschitz C, Kocijan R, Haschka J, et al. TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone. 2015;79:259-266. doi: 10.1016/j.bone.2015.06.007</mixed-citation><mixed-citation xml:lang="en">Muschitz C, Kocijan R, Haschka J, et al. TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone. 2015;79:259-266. doi: 10.1016/j.bone.2015.06.007</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Roux JP, Wegrzyn J, Boutroy S, Bouxsein ML, Hans D, Chapurlat R. The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study. Osteoporos Int. 2013;24(9):2455-2460. doi: 10.1007/s00198-013-2316-7</mixed-citation><mixed-citation xml:lang="en">Roux JP, Wegrzyn J, Boutroy S, Bouxsein ML, Hans D, Chapurlat R. The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study. Osteoporos Int. 2013;24(9):2455-2460. doi: 10.1007/s00198-013-2316-7</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Winzenrieth R, Dufour R, Pothuaud L, Hans D. A retrospective case-control study assessing the role of trabecular bone score in postmenopausal caucasian women with osteopenia: Analyzing the odds of vertebral fracture. Calcif Tissue Int. 2010. doi: 10.1007/s00223-009-9322-y</mixed-citation><mixed-citation xml:lang="en">Winzenrieth R, Dufour R, Pothuaud L, Hans D. A retrospective case-control study assessing the role of trabecular bone score in postmenopausal caucasian women with osteopenia: Analyzing the odds of vertebral fracture. Calcif Tissue Int. 2010. doi: 10.1007/s00223-009-9322-y</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McCloskey E V., Odén A, Harvey NC, et al. A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX. J Bone Miner Res. 2016;31(5):940-948. doi: 10.1002/jbmr.2734</mixed-citation><mixed-citation xml:lang="en">McCloskey E V., Odén A, Harvey NC, et al. A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX. J Bone Miner Res. 2016;31(5):940-948. doi: 10.1002/jbmr.2734</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Silva BC, Leslie WD, Resch H, et al. Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image. J Bone Miner Res. 2014;29(3):518-530. doi: 10.1002/jbmr.2176</mixed-citation><mixed-citation xml:lang="en">Silva BC, Leslie WD, Resch H, et al. Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image. J Bone Miner Res. 2014;29(3):518-530. doi: 10.1002/jbmr.2176</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Козырева М.В., Никитинская О.А., Торопцова Н.В. Трабекулярный костный индекс при ревматических заболеваниях // Научно-практическая ревматология. — 2022. — Т. 60. — № 6. — С. 587-593. doi: 10.47360/1995-4484-2022-587-59</mixed-citation><mixed-citation xml:lang="en">Kozyreva MV, Nikitinskaya OA, Toroptsova NV. Trabecular bone score in rheumatic disease. Rheumatology Science &amp; Practic. 2022;60(6):587-593. (In Russ.). doi: 10.47360/1995-4484-2022-587-59</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Leslie WD, Krieg M-A, Hans D. Clinical Factors Associated With Trabecular Bone Score. J Clin Densitom. 2013;16(3):374-379. doi: 10.1016/j.jocd.2013.01.006</mixed-citation><mixed-citation xml:lang="en">Leslie WD, Krieg M-A, Hans D. Clinical Factors Associated With Trabecular Bone Score. J Clin Densitom. 2013;16(3):374-379. doi: 10.1016/j.jocd.2013.01.006</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Buehring B, Thomas J, Wittkämper T, Baraliakos X, Braun J. Evaluation des Trabecular Bone Score (TBS) in der täglichen Praxis bei Patienten mit entzündlich rheumatischen und nichtentzündlichen Erkrankungen. Z Rheumatol. 2020. doi: 10.1007/s00393-020-00764-9</mixed-citation><mixed-citation xml:lang="en">Buehring B, Thomas J, Wittkämper T, Baraliakos X, Braun J. Evaluation des Trabecular Bone Score (TBS) in der täglichen Praxis bei Patienten mit entzündlich rheumatischen und nichtentzündlichen Erkrankungen. Z Rheumatol. 2020. doi: 10.1007/s00393-020-00764-9</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Choi YJ, Chung Y-S, Suh C-H, Jung J-Y, Kim H-A. Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2017;96(45):e8661. doi: 10.1097/MD.0000000000008661</mixed-citation><mixed-citation xml:lang="en">Choi YJ, Chung Y-S, Suh C-H, Jung J-Y, Kim H-A. Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2017;96(45):e8661. doi: 10.1097/MD.0000000000008661</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kim D, Cho SK, Kim JY et al. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis. Mod Rheumatol. 2016;26(4):540-5. doi: 10.3109/14397595.2015.1101212</mixed-citation><mixed-citation xml:lang="en">Kim D, Cho SK, Kim JY et al. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis. Mod Rheumatol. 2016;26(4):540-5. doi: 10.3109/14397595.2015.1101212</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lee KA, Kim HJ, Kim HS. Comparison of predictive value of FRAX, trabecular bone score, and bone mineral density for vertebral fractures in systemic sclerosis: A cross-sectional study. Medicine (Baltimore). 2023;102(2):e32580. doi: 10.1097/MD.0000000000032580</mixed-citation><mixed-citation xml:lang="en">Lee KA, Kim HJ, Kim HS. Comparison of predictive value of FRAX, trabecular bone score, and bone mineral density for vertebral fractures in systemic sclerosis: A cross-sectional study. Medicine (Baltimore). 2023;102(2):e32580. doi: 10.1097/MD.0000000000032580</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P. Bone fracture risk in patients with rheumatoid arthritis. Med (United States). 2017. doi: 10.1097/MD.0000000000006983</mixed-citation><mixed-citation xml:lang="en">Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P. Bone fracture risk in patients with rheumatoid arthritis. Med (United States). 2017. doi: 10.1097/MD.0000000000006983</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jin S, Hsieh E, Peng L et al. Incidence of fractures among patients with rheumatoid arthritis : a systematic review and meta-analysis. Osteoporos Int. 2018;29(6):1263-1275. doi: 10.1007/s00198-018-4473-1</mixed-citation><mixed-citation xml:lang="en">Jin S, Hsieh E, Peng L et al. Incidence of fractures among patients with rheumatoid arthritis : a systematic review and meta-analysis. Osteoporos Int. 2018;29(6):1263-1275. doi: 10.1007/s00198-018-4473-1</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Heinlen L, Humphrey MB. Skeletal complications of rheumatoid arthritis. Osteoporos Int. 2017;28(10):2801-2812. doi: 10.1007/s00198-017-4170-5</mixed-citation><mixed-citation xml:lang="en">Heinlen L, Humphrey MB. Skeletal complications of rheumatoid arthritis. Osteoporos Int. 2017;28(10):2801-2812. doi: 10.1007/s00198-017-4170-5</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Breban S, Briot K, Kolta S et al. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score. J Clin Densitom. 2012;15(3):260-6. doi: 10.1016/j.jocd.2012.01.007</mixed-citation><mixed-citation xml:lang="en">Breban S, Briot K, Kolta S et al. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score. J Clin Densitom. 2012;15(3):260-6. doi: 10.1016/j.jocd.2012.01.007</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lee KA, Kim J, Kim HJ, Kim HS. Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid. Int J Rheum Dis. 2021;24(8):1053-1060. doi: 10.1111/1756-185X.14164</mixed-citation><mixed-citation xml:lang="en">Lee KA, Kim J, Kim HJ, Kim HS. Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid. Int J Rheum Dis. 2021;24(8):1053-1060. doi: 10.1111/1756-185X.14164</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Buehring B, Thomas J, Wittkämper T et al. Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol. 2020;79(10):1067-1074. doi: 10.1007/s00393-020-00764-9</mixed-citation><mixed-citation xml:lang="en">Buehring B, Thomas J, Wittkämper T et al. Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol. 2020;79(10):1067-1074. doi: 10.1007/s00393-020-00764-9</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Popp AW, Meer S, Krieg MA et al. Bone mineral density (BMD) and vertebral trabecular bone score (TBS) for the identification of elderly women at high risk for fracture: the SEMOF cohort study. Eur Spine J. 2016;25(11):3432-3438. doi: 10.1007/s00586-015-4035-6</mixed-citation><mixed-citation xml:lang="en">Popp AW, Meer S, Krieg MA et al. Bone mineral density (BMD) and vertebral trabecular bone score (TBS) for the identification of elderly women at high risk for fracture: the SEMOF cohort study. Eur Spine J. 2016;25(11):3432-3438. doi: 10.1007/s00586-015-4035-6</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Tavassoli S, Rajaei A, Emam MM, Farsad F. Evaluating the Value-Added of the Trabecular Bone Score in Patients with Rheumatoid Arthritis. Arch Iran Med. 2021;24(3):193-198. URL: https://www.researchgate.net/publication/350907916_Evaluating_the_Value-Added_of_the_Trabecular_Bone_Score_in_Patients_with_Rheumatoid_Arthritis</mixed-citation><mixed-citation xml:lang="en">Tavassoli S, Rajaei A, Emam MM, Farsad F. Evaluating the Value-Added of the Trabecular Bone Score in Patients with Rheumatoid Arthritis. Arch Iran Med. 2021;24(3):193-198. URL: https://www.researchgate.net/publication/350907916_Evaluating_the_Value-Added_of_the_Trabecular_Bone_Score_in_Patients_with_Rheumatoid_Arthritis</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Corrado A, Rotondo C, Mele A, et al. Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis. Arthritis Res Ther. 2021;23(1):180. doi: 10.1186/s13075-021-02562-3</mixed-citation><mixed-citation xml:lang="en">Corrado A, Rotondo C, Mele A, et al. Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis. Arthritis Res Ther. 2021;23(1):180. doi: 10.1186/s13075-021-02562-3</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
